HMGB1 and lupus nephritis: Moreover, they establish HMGB1, TLR4, and MYD88 as novel molecular markers for NETs-mediated renal inflammatory damage in lupus nephritis, providing new targets for the prevention, diagnosis, and treatment of this condition.